Skip to main content
. 2005 May 31;92(11):1976–1983. doi: 10.1038/sj.bjc.6602572

Table 4. Non-fluoropyrimidine toxicity according to fluoropyrimidine dose.

  ECF 200
EOF 200
ECX 500
EOX 500
ECX 625
EOX 625
Toxicity (grade 3/4) No. of pts/total % No. of pts/total % No. of pts/total % No. of pts/total % No. of pts/total % No. of pts/total %
Nauseaa 2/47 4 7/50 14 1/27 4 2/32 6 0/16 0 2/16 12
Alopeciab 21/47 50 18/50 36 12/27 44 10/32 31 5/16 31 3/16 19
Lethargy 8/46 17 10/50 20 3/27 11 5/32 16 1/16 6 3/16 19
Peripheral neuropathya 0/47 0 3/50 6 1/27 4 0/32 0 0/16 0 2/16 12
Neutropenia 16/47 34 12/49 24 9/25 36 15/32 46 6/15 40 4/16 25
Thrombocytopeniaa 2/47 4 4/49 8 4/26 15 2/32 6 0/15 0 1/16 6
Infectiona 6/47 13 10/50 20 1/27 4 2/32 6 1/16 6 4/16 25
Febrile neutropenia 2/24 8 4/29 14 1/10 10 0/14 0 0/14 0 3/16 19
Anaemia 8/47 17 2/49 4 2/26 8 3/32 9 1/15 7 1/16 6
a

No grade 4 toxicity.

b

CTC grade 2 alopecia.

Pts=patients; ECF=epirubicin, cisplatin, 5-fluorouracil; ECX=epirubicin, cisplatin, capecitabine; EOF=epirubicin, oxaliplatin, 5-fluorouracil; EOX=epirubicin, oxaliplatin, capecitabine.